Concourse Financial Group Securities’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Hold |
0
| – | – | – | 10358 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 10132 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 9762 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 9770 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 9574 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 9391 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 9170 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8801 |
|
|
2021
Q3 | – | Sell |
-165
| Closed | -$23K | – | 8255 |
|
|
2021
Q2 | $23K | Hold |
165
| – | – | ﹤0.01% | 1608 |
|
|
2021
Q1 | $16K | Hold |
165
| – | – | ﹤0.01% | 1635 |
|
|
2020
Q4 | $20K | Hold |
165
| – | – | ﹤0.01% | 1466 |
|
|
2020
Q3 | $16K | Hold |
165
| – | – | ﹤0.01% | 1434 |
|
|
2020
Q2 | $26K | Hold |
165
| – | – | ﹤0.01% | 1210 |
|
|
2020
Q1 | $24K | Hold |
165
| – | – | ﹤0.01% | 1180 |
|
|
2019
Q4 | $34K | Hold |
165
| – | – | ﹤0.01% | 1083 |
|
|
2019
Q3 | $13K | Hold |
165
| – | – | ﹤0.01% | 1086 |
|
|
2019
Q2 | $16K | Hold |
165
| – | – | ﹤0.01% | 1341 |
|
|
2019
Q1 | $14K | Hold |
165
| – | – | ﹤0.01% | 1410 |
|
|
2018
Q4 | $9K | Hold |
165
| – | – | ﹤0.01% | 1471 |
|
|
2018
Q3 | $13K | Buy |
+165
| New | +$13K | ﹤0.01% | 1020 |
|